Business Wire

ASDA Partners With Avery Berkel and Hanshow to Enhance UK Sustainability and Supermarket Shopping Experience

25.7.2023 11:00:00 EEST | Business Wire | Press release

Share

ASDA, in partnership with Avery Berkel and Hanshow, has launched a strategic project to create the first sustainability trial store in the UK that utilizes leading ESL technology and digital retail solutions to enhance operations and improve the shopping experience for customers. This partnership aims to promote refillable solutions for supermarket shopping in the UK, with a focus on sustainability and customer experience. Avery Berkel and Hanshow collaborated to leverage their expertise in retail scales, enterprise scale management, and electronic shelf labels (ESLs) to develop a sustainable solution for the Middleton store, eliminating the need for physical labels and creating a zero-waste solution for ASDA.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230713235215/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Avery Berkel and Hanshow's solutions installed in ASDA (Photo: Business Wire)

The solutions offered by Avery Berkel and Hanshow allow ASDA to carry out its commitment to zero-waste shopping through its bring-your-own-container solution and promoting its ‘Refill Price Promise’ program, which guarantees lower prices to help customers shop more sustainably. ESL technology reduces the cost and time of manual updates, while allowing ASDA to make real-time changes to prices and promotions. It also allows customers to see price differences in wrapped and unwrapped versions of the same product. The solutions make it easier for customers to shop sustainably and are part of a greater effort to make ASDA’s refill areas more efficient and green.

Avery Berkel and Hanshow’s ESL technology streamlines in-store change administration and management, ensuring real-time price and product updates to keep shelves up to date and compliant with regulations. This flexibility to adjust prices and promotions enables retailers to respond promptly to market trends and customer demands, while reducing costs associated with label stock holding and consumables. Increased productivity and efficiency allow employees to focus on providing better customer service.

Customizability is another key feature of the ESL technology innovations, enabling ASDA and other retailers to incorporate custom fonts, images, logos, and graphics into the labels. This allows for brand alignment and a consistent visual identity across stores. The on-screen barcodes and QR codes facilitate easy scanning, streamlining checkout processes and enhancing operational efficiency.

The components of Avery Berkel and Hanshow’s solution are seamlessly integrated to provide shoppers with an enriching refill experience while emphasizing sustainability. Unlike standard printed shelf and product labels, the total refill solution offers additional product information such as refill instructions, ingredients, allergens, and storage details, encouraging sustainability in ASDA stores.

Avery Berkel and Hanshow aimed to revolutionize the shopping experience by making sustainable choices more accessible and engaging for customers. The shopper interface, designed to be simple and intuitive, ensures that even customers unfamiliar with this technology can easily navigate and participate. The collaboration among ASDA, Avery Berkel and Hanshow has led to a total solution that not only benefits the retail industry and its customers, but also provides a green solution and encourages more environmentally friendly retail practices and shopping habits. Consumer demand for sustainable retail will continue to grow in the future. Hanshow will strive to provide the sustainable retail solutions by continuously innovating and improving their digital labelling technology to meet the changing needs of customers and reduce environmental impact.

About Hanshow

Hanshow is a global leader in developing and manufacturing electronic shelf labels and digital store solutions. The company offers customers a series of customized IoT touchpoints and digital store solutions that deliver customer-centric insights. Hanshow's solutions have provided services to a vast number of stores across over 50 countries and regions, helping them streamline operations, optimize pricing strategies, and offer consumers a more personalized experience. Learn more: www.hanshow.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Zishan Cai
zishan.cai@hanshow.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Datroway ® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 09:30:00 EEST | Press release

Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on results from the TROPION-Breast02phase 3 trial, which were presented at the 2025 European Society for Medical Oncology Congress and subsequently published in Annals of Oncology. In TROPION-Breast02, which included patients with metastatic TNBC who experienced early relapse following prior treatment, Datroway demonstrated a statis

Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 09:30:00 EEST | Press release

Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said

Half-Year Report on SES’s Liquidity Contract31.7.2026 08:30:00 EEST | Press release

Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th

SES: Disclosure of Share Buyback Transactions31.7.2026 08:30:00 EEST | Press release

In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin

SES Publishes FY2025 EU Taxonomy Restatement31.7.2026 08:30:00 EEST | Press release

SES today published a restatement of its FY2025 EU Taxonomy (Article 8) disclosure. The restatement updates the FY2025 EU Taxonomy disclosure included in the 2025 Annual Report and supersedes the previously published disclosure. The FY2025 EU Taxonomy Restatement is available on the SES website: https://www.ses.com/sites/ses_v2/files/investor-files/2026-07/EU_Taxonomy_Report_Restatement_2025.pdf Follow us on: X | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where they are. With integrated multi-orbit satellites and our global terrestrial network, we deliver resilient, seamless connectivity and the highest quality video content to those shaping what’s next. Following our Intelsat acquisition, we now offer more than 100 years of combined global industry l

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye